Skip to main content

Protectors of Biology & Providers of Hope

The human body is an amazing machine that is capable of self-repair. This innate functionality to repair wounds is remarkably potent during our younger years, but as we age our regenerative capabilities diminish. Fortunately, we have the opportunity to supplement wound repair through the use of human cell and tissue products (HCT/P) derived from birthing tissues such as placental membranes.

DermaBind is approved by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271

Advanced Wound Cover For Non-Healing Wounds

Dermabind is a dehydrated, intact placental wound cover. Our process does not separate the amnion and chorion layers, which helps preserve the intermediate layer that contains naturally present proteins, collagens, and glycoproteins.

  • Non Immunogenic

  • Natural Biological Barrier

Dermabind is terminally sterilized using gamma irradiation, is never frozen, and is completely free of preservatives. This allows Dermabind to maintain its shape and protect the proteins and structures that provide the characteristics crucial to the membrane’s function as a biological covering.

Preservation through Process

Equipped with state-of-the-art laboratory processes to ensure the safety and integrity of its products. Our laboratory and proprietary processes maintain the tissue’s biological components with minimal degradation of native proteins.

Protecting biology

Our processing removes any cellular remnants and sterilizes the placental membrane without loss of the important components crucial to the function of the membrane as a biological covering.

To maintain the natural characteristics of the placental membrane, no chemicals or antibiotics are used. This ensures that there is no risk of selecting antibiotic-resistant bacteria and no chemical dehydration means no risk of residual irritants or chemical denaturation of protein.

Placental membrane - Nature’s gift.

Anatomically, the human placental membranes surround the fetus and separate it from maternal tissue. The membrane provides elasticity and strength to hold, cushion, and protect a developing fetus and acts as a critical barrier, preventing mixing of maternal and fetal blood and the transfer of pathogens, while allowing key nutrients to pass to the fetus.
The proteins and collagen matrix of the placental membrane provide a natural covering and barrier that supports the body’s ability to repair.

The proteins and collagen matrix of the placental membrane provide a natural covering and barrier that supports the body’s ability to recruit the necessary biological components for wound closure.

Allografts covered by Medicare

Q 4225

Sizes

AMB7
6.5cm x 6.5cm

AMB4
4cm x 4cm

AMB3
3cm x 3cm

AMB2
2cm x 2cm

Q 4313

Sizes

DFM7
6.5cm x 6.5cm

DFM4
4cm x 4cm

DFM3
3cm x 3cm

DFM2
2cm x 2cm

Frequently asked questions

The DermaBind Process

DermaBind undergoes a proprietary preservation method, which retains all native layers of the placental membrane, including the amnion and chorion with the spongy layer intact, unlike many placental allografts on the market.

The DermaBind TL process does not use unnecessary chemicals, antibiotics or preservatives and is never frozen.

The finished product is physician-friendly, durable, easily applied to a wound and can be stored at room temperature for up to 3 years.

Composition

DermaBind contains 400+ proteins, including collagens, fibrins, elastins, glucosaminoglycans and glycoconjugates.

Intended Use

DermaBind can be used as a protective wound covering as either a partial and full thickness acute and chronic wounds.

  • Trauma Wounds
  • Pressure Injuries
  • Dehisced Wounds
  • Wounds with Exposed Bone/Tendon
  • Venous Leg Ulcers (VLUs)
  • Diabetic Foot Ulcers (DFUs)

Application

  • Using aseptic technique, remove DermaBind TL from the package; the product may be trimmed as necessary
  • Place the DermaBind TL patch onto the wound
  • Assure DermaBind TL is in intimate contact with the wound bed; the product can be hydrated once placed on the wound bed
  • Adhere DermaBind TL using preferred fixation method, then cover DermaBind TL with a primary nonadherent dressing
  • Apply secondary dressings specific to the wound type over the non-adherent layer, which should remain in place for up to one week

Size & Storage

  • Available in a wide range of shapes and sizes
  • Maintain at ambient temperature prior to patient application
  • Do not freeze
  • May be stored for up to 3 years at room temperature.

Sizes

  • 6.5cm x 6.5cm
  • 4cm x 4cm
  • 3cm x 3cm
  • 2cm x 2cm